Company SCHOTT Pharma AG & Co. KGaA
Equities
1SXP
DE000A3ENQ51
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.52 EUR | -1.50% | -14.02% | -6.19% |
05-15 | Barclays lowers Schott Pharma target to 25 euros - 'Equal Weight' | DP |
05-15 | SCHOTT PHARMA : Deutsche Bank reiterates its Buy rating | ZD |
Business Summary
Number of employees: 4,687
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Containment Solutions
61.8
%
| 598 | 72.9 % | 555 | 61.8 % | -7.24% |
Drug Delivery Systems
38.2
%
| 223 | 27.1 % | 344 | 38.2 % | +54.20% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
EMEA
50.0
%
| 331 | 40.3 % | 449 | 50.0 % | +35.72% |
North America
18.1
%
| 181 | 22.0 % | 162 | 18.1 % | -10.01% |
Germany
11.5
%
| 92 | 11.3 % | 103 | 11.5 % | +11.44% |
Asia and South Pacific
11.3
%
| 129 | 15.7 % | 102 | 11.3 % | -21.00% |
South America
9.1
%
| 88 | 10.7 % | 82 | 9.1 % | -7.09% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andreas Reisse
CEO | Chief Executive Officer | 63 | 22-06-30 |
Director of Finance/CFO | 43 | 22-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eva Kienle
BRD | Director/Board Member | 57 | 23-04-03 |
Wolfgang Wienand
BRD | Director/Board Member | 52 | 23-04-03 |
Chairman | 59 | 23-04-03 | |
Director/Board Member | 49 | 23-04-03 | |
Christine Wening
BRD | Director/Board Member | 44 | 23-04-18 |
Mario Just
BRD | Director/Board Member | 58 | 23-04-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 150,614,616 | 34,641,362 ( 23.00 %) | 0 | 23.00 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.19% | 5.16B | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.52% | 42.73B | |
+25.54% | 32.52B | |
+17.85% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- 1SXP Stock
- Company SCHOTT Pharma AG & Co. KGaA